1569P A multicenter analysis of the outcome of cancer patients with neutropenia and COVID-19 infection optionally treated with granulocyte colony-stimulating factor (G-CSF): A comparative analysis

Ann Oncol · 2021 · PMC8454425

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

In G-CSF treated cohort, we found that the days with G-CSF showed a significant trend toward worse outcome and higher mortality.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.